Harmony Consulting Blog

What Are the Best Practices for Implementing a Quality Management System in the Pharmaceutical Industry? Key Components and Compliance Strategies Explained

Implementing a Quality Management System (QMS) in the pharmaceutical industry is a critical step to ensure product safety, regulatory compliance, and patient trust. This article offers a high-level overview of…

Beyond Compliance: How Regulatory Consultants Add Strategic Value to Pharma and Biotech Companies

Pharma and biotech companies operate in an environment filled with complex regulations designed to ensure patient safety and product efficacy. But regulatory compliance is only one part of the story.…

Top Regulatory Requirements To Be Aware Of For Biotech Product Approval in 2026

The biotech industry is advancing faster than ever. New therapies and technologies hold promise to transform healthcare. But to reach patients, these innovations must clear complex regulatory hurdles. For companies…

A Comprehensive Overview of Biotech Regulatory Consulting Services for Pharmaceutical Companies

Bringing a new drug, device, diagnostic, or biotech therapy to market is a complex journey. It involves navigating a web of regulatory requirements designed to ensure safety, efficacy, and quality.…

Onshoring Decision-Making: A Practical Overview for Biotech Manufacturing

Onshoring is not about abandoning global integration, it’s about recalibrating it. For biotech companies, the goal is a resilient, adaptive manufacturing network that balances efficiency with control. Domestic production can…

How AI Is Redefining Quality Management in Biotech

Quality management in biotechnology has always been about walking a tightrope. On one side lies the imperative to protect patient safety through rigorous controls and documentation. On the other, the…

How Onshoring Is Reshaping Biotech Manufacturing

For decades, biotech manufacturing thrived on globalization. A molecule might be discovered in Boston, scaled in Singapore, and filled and finished in Ireland — all part of an intricate web…

What Regulatory Agencies Expect During Process Scale-Up: A Practical Guide for Biotechs

Scaling a promising therapeutic from lab bench to commercial production is one of the most defining transitions in a biotech’s lifecycle. It’s also one of the most closely scrutinized. As…

How Federal Funding Is Impacted by Government Shutdowns And What Biotechs Should Expect When It’s Over

When the federal government shuts down, Washington D.C. doesn’t actually close — it constricts. For biotech organizations that rely on federal grants, contracts, regulatory interactions or collaborations with government-labs, a…

5 Ways to Put Development at Risk by Doing too Little

Phase-Appropriate Development: #2 We need to comply with FDA requirements. How much is enough? If the basics are not in place, then development will not move forward. Studies will need…